Search

Your search keyword '"Becerra, Carlos"' showing total 759 results

Search Constraints

Start Over You searched for: Author "Becerra, Carlos" Remove constraint Author: "Becerra, Carlos"
759 results on '"Becerra, Carlos"'

Search Results

1. PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial

3. Contributors

4. Molecular and cell biology of cervical cancer

5. Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

6. YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies

8. Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors

9. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

10. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

14. Open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-175 in human leukocyte antigen-a*02:01-positive adult subjects with unresectable, advanced and/or metastatic solid tumors that are positive for the TP53 R175H mutation.

15. A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

17. Contributors

18. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

21. A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma

23. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

24. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial.

25. Gestión tributaria municipal. Estudio de caso en los municipios de Norte de Santander, Colombia, en el periodo 1995-2023.

26. X‐Ray Visible Protein Scaffolds by Bulk Iodination

29. 596 AMBER, Part 2B: a phase 1 study of cobolimab plus dostarlimab in patients with advanced/metastatic non-small cell lung cancer (NSCLC) previously treated with anti-PD(L)-1 therapy

30. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

32. A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer

33. Essentializing Origins: Ethnoracialization of Immigrants in the U.S. Context

36. YKL-40 serum levels are predicted by inflammatory state, age and diagnosis of idiopathic inflammatory myopathies

38. Aortic stiffness and central hemodynamics in treatment-naïve HIV infection: a cross-sectional study

39. X‐Ray Visible Protein Scaffolds by Bulk Iodination.

40. Variable association of 24-h peripheral and central hemodynamics and stiffness with hypertension-mediated organ damage: the VASOTENS Registry

41. Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

46. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

50. Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer

Catalog

Books, media, physical & digital resources